Novolog Pharm-Up 1966 Ltd (NVLG) — Cash Flow Quality Index
Novolog Pharm-Up 1966 Ltd (NVLG) has a Cash Flow Quality Index of 3.61x as of September 2025. Operating cash flow of ILA15.42 Million exceeds net income of ILA4.27 Million, indicating high earnings quality where cash backs reported profits. Explore Novolog Pharm-Up 1966 Ltd (NVLG) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Novolog Pharm-Up 1966 Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Novolog Pharm-Up 1966 Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NVLG goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Novolog Pharm-Up 1966 Ltd (2013–2025)
Year-by-year earnings quality comparison for Novolog Pharm-Up 1966 Ltd. For live market cap and the full company financial profile, see NVLG market cap overview.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -4.01x | ILA-16.50 Million | ILA4.12 Million | ▼ -203.7% |
| 2024 | 3.87x | ILA158.52 Million | ILA40.99 Million | ▲ +49.8% |
| 2022 | 2.58x | ILA132.65 Million | ILA51.40 Million | ▲ +38.7% |
| 2021 | 1.86x | ILA83.39 Million | ILA44.83 Million | ▲ +29.0% |
| 2020 | 1.44x | ILA58.48 Million | ILA40.56 Million | ▼ -85.6% |
| 2019 | 10.01x | ILA101.45 Million | ILA10.14 Million | ▲ +813.0% |
| 2018 | 1.10x | ILA23.96 Million | ILA21.86 Million | ▼ -71.5% |
| 2017 | 3.84x | ILA86.37 Million | ILA22.49 Million | ▲ +451.3% |
| 2016 | 0.70x | ILA20.28 Million | ILA29.12 Million | ▼ -87.5% |
| 2015 | 5.55x | ILA140.29 Million | ILA25.26 Million | ▼ -18.6% |
| 2014 | 6.82x | ILA160.59 Million | ILA23.54 Million | ▲ +280.8% |
| 2013 | -3.77x | ILA-55.79 Million | ILA14.79 Million | — |